| JAK2 Exon 12 Mutations in Polycythemia Vera and Idiopathic Erythrocytosis LM Scott, W Tong, RL Levine, MA Scott, PA Beer, MR Stratton, PA Futreal, ... New England Journal of Medicine 356 (5), 459-468, 2007 | 1721 | 2007 |
| Prediction of acute myeloid leukaemia risk in healthy individuals S Abelson, G Collord, SWK Ng, O Weissbrod, N Mendelson Cohen, ... Nature 559 (7714), 400-404, 2018 | 775 | 2018 |
| MPL mutations in myeloproliferative disorders: analysis of the PT-1 cohort PA Beer, PJ Campbell, LM Scott, AJ Bench, WN Erber, D Bareford, ... Blood, The Journal of the American Society of Hematology 112 (1), 141-149, 2008 | 576 | 2008 |
| Mutation of JAK2 in the myeloproliferative disorders: timing, clonality studies, cytogenetic associations, and role in leukemic transformation PJ Campbell, EJ Baxter, PA Beer, LM Scott, AJ Bench, BJP Huntly, ... Blood 108 (10), 3548-3555, 2006 | 377 | 2006 |
| The Lin28b–let-7–Hmga2 axis determines the higher self-renewal potential of fetal haematopoietic stem cells MR Copley, S Babovic, C Benz, DJHF Knapp, PA Beer, DG Kent, ... Nature cell biology 15 (8), 916-925, 2013 | 354 | 2013 |
| Targeted sequencing in DLBCL, molecular subtypes, and outcomes: a Haematological Malignancy Research Network report SE Lacy, SL Barrans, PA Beer, D Painter, AG Smith, E Roman, SL Cooke, ... Blood, The Journal of the American Society of Hematology 135 (20), 1759-1771, 2020 | 348 | 2020 |
| Somatic Mutations of IDH1 and IDH2 in the Leukemic Transformation of Myeloproliferative Neoplasms A Green, P Beer New England Journal of Medicine 362 (4), 369-370, 2010 | 347 | 2010 |
| Two routes to leukemic transformation after a JAK2 mutation–positive myeloproliferative neoplasm PA Beer, F Delhommeau, JP LeCouédic, MA Dawson, E Chen, ... Blood, The Journal of the American Society of Hematology 115 (14), 2891-2900, 2010 | 328 | 2010 |
| Correlation of blood counts with vascular complications in essential thrombocythemia: analysis of the prospective PT1 cohort PJ Campbell, C MacLean, PA Beer, G Buck, K Wheatley, JJ Kiladjian, ... Blood, The Journal of the American Society of Hematology 120 (7), 1409-1411, 2012 | 247 | 2012 |
| JAK2 V617F impairs hematopoietic stem cell function in a conditional knock-in mouse model of JAK2 V617F–positive essential thrombocythemia J Li, D Spensberger, JS Ahn, S Anand, PA Beer, C Ghevaert, E Chen, ... Blood, The Journal of the American Society of Hematology 116 (9), 1528-1538, 2010 | 239 | 2010 |
| Hematopoietic stem cell heterogeneity takes center stage MR Copley, PA Beer, CJ Eaves Cell stem cell 10 (6), 690-697, 2012 | 226 | 2012 |
| Distinct clinical phenotypes associated with JAK2V617F reflect differential STAT1 signaling E Chen, PA Beer, AL Godfrey, CA Ortmann, J Li, AP Costa-Pereira, ... Cancer cell 18 (5), 524-535, 2010 | 209 | 2010 |
| A novel erythrocytosis-associated PHD2 mutation suggests the location of a HIF binding groove MJ Percy, PW Furlow, PA Beer, TRJ Lappin, MF McMullin, FS Lee Blood, The Journal of the American Society of Hematology 110 (6), 2193-2196, 2007 | 191 | 2007 |
| Guideline for the investigation and management of eosinophilia N Butt, J Lambert, S Ali, P Beer, N Cross, A Duncombe, J Ewing, ... British journal of haematology 176 (4), 2017 | 158 | 2017 |
| Guideline for the investigation and management of eosinophilia N Butt, J Lambert, S Ali, P Beer, N Cross, A Duncombe, J Ewing, ... British journal of haematology 176 (4), 2017 | 158 | 2017 |
| How I treat essential thrombocythemia PA Beer, WN Erber, PJ Campbell, AR Green Blood, The Journal of the American Society of Hematology 117 (5), 1472-1482, 2011 | 153 | 2011 |
| Novel exon 12 mutations in the HIF2A gene associated with erythrocytosis MJ Percy, PA Beer, G Campbell, AW Dekker, AR Green, D Oscier, ... Blood, The Journal of the American Society of Hematology 111 (11), 5400-5402, 2008 | 153 | 2008 |
| Guideline for the diagnosis and management of myelofibrosis JT Reilly, MF McMullin, PA Beer, N Butt, E Conneally, A Duncombe, ... British journal of haematology 158 (4), 453-471, 2012 | 147 | 2012 |
| Clinical utility of routine MPL exon 10 analysis in the diagnosis of essential thrombocythaemia and primary myelofibrosis EM Boyd, AJ Bench, A Goday‐Fernández, S Anand, KJ Vaghela, P Beer, ... British journal of haematology 149 (2), 250-257, 2010 | 139 | 2010 |
| The JAK2 46/1 haplotype predisposes to MPL-mutated myeloproliferative neoplasms AV Jones, PJ Campbell, PA Beer, S Schnittger, AM Vannucchi, K Zoi, ... Blood, The Journal of the American Society of Hematology 115 (22), 4517-4523, 2010 | 127 | 2010 |
